72224-25-0 Usage
Uses
Used in Pharmaceutical Industry:
(R,S)-4-(2,3-Epoxypropoxy)phenylacetic acid is used as a key intermediate for the development of various drugs and biologically active compounds. Its epoxy group allows for the creation of new and unique chemical structures, contributing to the advancement of medicinal chemistry and the discovery of novel therapeutic agents.
Used in Agrochemical Industry:
(R,S)-4-(2,3-Epoxypropoxy)phenylacetic acid is used as a building block in the synthesis of agrochemical products, such as pesticides and other crop protection agents. Its versatile chemical structure enables the development of innovative and effective solutions for agricultural applications, enhancing crop yield and protection against pests and diseases.
Used in Chemical Research:
(R,S)-4-(2,3-Epoxypropoxy)phenylacetic acid serves as a valuable compound in chemical research, particularly in the study of chiral compounds and their applications. Its different geometric arrangements of atoms, (R) and (S) forms, provide opportunities for exploring the properties and potential uses of chiral molecules in various fields, including pharmaceuticals, materials science, and environmental science.
Check Digit Verification of cas no
The CAS Registry Mumber 72224-25-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,2,2 and 4 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 72224-25:
(7*7)+(6*2)+(5*2)+(4*2)+(3*4)+(2*2)+(1*5)=100
100 % 10 = 0
So 72224-25-0 is a valid CAS Registry Number.
72224-25-0Relevant academic research and scientific papers
(S)-1-[2-(4-HYDROXY-S-(1-ALKYLAMINO-PROPOXY)PHENYLALKYL]-4-PHENYLPIPERAZINES
-
, (2008/06/13)
There are disclosed compounds of the formula STR1 wherein R 1 is selected from the group consisting of lower alkyl; R 8 is selected from the group consisting of--O--(CH 2) n--wherein n is 2 to 20, STR2 and R 6 is selected from the group consisting of hydrogen or lower alkoxy, and STR3 wherein R 1 is selected from the group consisting of lower alkyl; R 8 is selected from the group consisting of--O--(CH 2) n--wherein n is 2 to 20, STR4 and R 6 is selected from the group consisting of hydrogen or lower alkoxy and racemates thereof.There are also disclosed processes and intermediates utilized to produce the end products. The end products have utility as agents exhibiting both α and selective β adrenergic blocking action.
